Acción BIO.B BIO-RAD LABORATORIES, INC.
Añadir a una lista
Para utilizar esta función debe ser un cliente o miembro.
ConéctateRegístrate

Otros idiomas Bio-Rad Laboratories, Inc. Nyse

Acciones

BIO.B

US0905721082

Mercado cerrado - Nyse
Otros sitios de cotización
 22:15:00 17/05/2024 		Varia. Cinco días. Varia. 1 de enero.
279,9 USD 0,00 % Gráfico intradía de Bio-Rad Laboratories, Inc. 0,00 % -12,71 %
14/05 Transcript : Bio-Rad Laboratories, Inc. Presents at 2024 RBC Capital Markets Global Healthcare Conference, May-14-2024 02:05 PM
08/05 BIO-RAD LABORATORIES, INC. : UBS reitera su recomendación de compra ZM

Otros idiomas

Buscar
Ver los resultados
Desbloquee todas las noticias sobre todas las empresas: ¡No vuelvas a perderse una oportunidad de inversión rentable!
Inscripción 100% Gratuita
Bio-Rad Laboratories reiterates 2024 revenue growth outlook; shares slip
Bio-Rad Laboratories Q1 Non-GAAP Earnings, Revenue Decline
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 Revenue $610.8M, vs. Street Est of $620.1M
Earnings Flash (BIO) BIO-RAD LABORATORIES Reports Q1 EPS $2.29, vs. Street Est of $2.14
Bio-Rad: Q1 Earnings Snapshot
Bio-Rad Reports First-Quarter 2024 Financial Results
Bio-Rad Laboratories, Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024
Bio-Rad's Management to Participate in Fireside Chat during RBC Capital Markets Global Healthcare Conference
Bio-Rad’s Management to Participate in Fireside Chat During RBC Capital Markets Global Healthcare Conference
Bio-Rad Announces Life Science Group Management Changes
Bio-Rad Announces Life Science Group Management Changes
Bio-Rad Laboratories, Inc. Announces Executive Vice President and President Changes, Life Science Group
Bio-Rad to Report First Quarter 2024 Financial Results on Tuesday, May 7, 2024
ONCOCYTE REPORTS FULL YEAR 2023 FINANCIAL RESULTS
Oncocyte and Bio-Rad Partner on Global Launch of Transplant Assay
Oncocyte Corporation and Bio-Rad Laboratories, Inc. Partner on Global Launch of Transplant Assay
Bio-Rad Laboratories COO Andrew Last to Retire in September
Bio-Rad’s Chief Operating Officer Andrew Last to Retire
Bio-Rad Laboratories, Inc. Announces Chief Operating Officer Andrew Last to Retire
North American Morning Briefing : Focus Turns to -2-
No hay resultados para esta búsqueda
Todas Recomendaciones analistas Eventos destacados Insiders Transcripts Comunicados Publs. oficiales Otros idiomas Ideas de trading Artículos de MarketScreener Estrategias MarketScreener

Filtros

Buscar

Fecha de publicación

De

Hasta

  1. Bolsa de valores
  2. Acciones
  3. Acción BIO
  4. Acción BIO.B
  5. Noticias Bio-Rad Laboratories, Inc.
  6. Otros idiomas